4AL-JANABI S,HUISMAN A,NAP M,et al.Whole slide images as a platform for initial diagnostics in histopathology in a medium-sized routine laboratory[J].J Clin Pathol,2012,65(12):1107-1111.
5WEINSTEIN RS,GRAHAM AR,RIAHTER LC,et al.Overview of telepathology,virtual microscopy,and whole slide imaging:prospects for the future[J].Hum Pathol,2009,40(8):1057-1069.
6AL-JANABI S,HUISMAM A,VAN DIEST PJ.Digital pathology:current status and future perspectives[J].Histopathology,2012,61(1):1-9.
7GAVRIELIDES MA,GALLAS BD,LENZ P,et al.Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy[J].Arch Pathol Lab Med,2011,135(2):233-242.
8SHAH SS,KETTERLING RP,GOETZ MP,et al.Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer[J].Human Pathology,2010,41(1):103-106.
9BANG YJ,VAN CUTSEM E,FEYEREISLOVA A,et al.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA):a phase 3,open-label,randomised controlled trial[J].Lancet,2010,376(9742):687-697.
10AJANI JA,BENTREM DJ,BESH S,et al.Gastric cancer,version 2.2013:featured updates to the NCCN Guidelines[J].J Natl Compr Canc Netw,2013,11(5):531-546.
